These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29348618)

  • 1. Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice.
    Franko A; Rodriguez Camargo DC; Böddrich A; Garg D; Rodriguez Camargo A; Rathkolb B; Janik D; Aichler M; Feuchtinger A; Neff F; Fuchs H; Wanker EE; Reif B; Häring HU; Peter A; Hrabě de Angelis M
    Sci Rep; 2018 Jan; 8(1):1116. PubMed ID: 29348618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory Mechanism of Epigallocatechin Gallate on Fibrillation and Aggregation of Amidated Human Islet Amyloid Polypeptide.
    Xu ZX; Ma GL; Zhang Q; Chen CH; He YM; Xu LH; Zhou GR; Li ZH; Yang HJ; Zhou P
    Chemphyschem; 2017 Jun; 18(12):1611-1619. PubMed ID: 28297133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
    de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid Polypeptide.
    Xu ZX; Zhang Q; Ma GL; Chen CH; He YM; Xu LH; Zhang Y; Zhou GR; Li ZH; Yang HJ; Zhou P
    J Diabetes Res; 2016; 2016():1867059. PubMed ID: 28074190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice.
    Wijesekara N; Kaur A; Westwell-Roper C; Nackiewicz D; Soukhatcheva G; Hayden MR; Verchere CB
    Diabetologia; 2016 Jun; 59(6):1242-6. PubMed ID: 26970755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc boosts EGCG's hIAPP amyloid Inhibition both in solution and membrane.
    Lee YH; Lin Y; Cox SJ; Kinoshita M; Sahoo BR; Ivanova M; Ramamoorthy A
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):529-536. PubMed ID: 30468883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate.
    Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azadirachtin inhibits amyloid formation, disaggregates pre-formed fibrils and protects pancreatic β-cells from human islet amyloid polypeptide/amylin-induced cytotoxicity.
    Dubey R; Patil K; Dantu SC; Sardesai DM; Bhatia P; Malik N; Acharya JD; Sarkar S; Ghosh S; Chakrabarti R; Sharma S; Kumar A
    Biochem J; 2019 Mar; 476(5):889-907. PubMed ID: 30814273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
    Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
    Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-epigallocatechin-3-gallate inhibits fibrillogenesis of chicken cystatin.
    Wang N; He J; Chang AK; Wang Y; Xu L; Chong X; Lu X; Sun Y; Xia X; Li H; Zhang B; Song Y; Kato A; Jones GW
    J Agric Food Chem; 2015 Feb; 63(5):1347-51. PubMed ID: 25620201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment.
    Montane J; de Pablo S; Castaño C; Rodríguez-Comas J; Cadavez L; Obach M; Visa M; Alcarraz-Vizán G; Sanchez-Martinez M; Nonell-Canals A; Parrizas M; Servitja JM; Novials A
    FASEB J; 2017 Dec; 31(12):5296-5306. PubMed ID: 28821639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibition Effect of Epigallocatechin-3-Gallate on the Co-Aggregation of Amyloid-β and Human Islet Amyloid Polypeptide Revealed by Replica Exchange Molecular Dynamics Simulations.
    Li X; Zhang Y; Yang Z; Zhang S; Zhang L
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice.
    Westwell-Roper CY; Chehroudi CA; Denroche HC; Courtade JA; Ehses JA; Verchere CB
    Diabetologia; 2015 Mar; 58(3):575-85. PubMed ID: 25491100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
    J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinopeptide formation associated with the disruptive effect of epigallocatechin-gallate on lysozyme fibrils.
    Cao N; Zhang YJ; Feng S; Zeng CM
    Int J Biol Macromol; 2015; 78():389-95. PubMed ID: 25931397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.
    Meng F; Abedini A; Plesner A; Verchere CB; Raleigh DP
    Biochemistry; 2010 Sep; 49(37):8127-33. PubMed ID: 20707388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
    Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
    Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin Gallate Remodels Fibrils of Lattice Corneal Dystrophy Protein, Facilitating Proteolytic Degradation and Preventing Formation of Membrane-Permeabilizing Species.
    Stenvang M; Christiansen G; Otzen DE
    Biochemistry; 2016 Apr; 55(16):2344-57. PubMed ID: 27042751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of hypoglycemic agents to target human islet amyloid polypeptide: a key protein involved in amyloid deposition and beta-cell loss.
    Fortin JS; Benoit-Biancamano MO
    Can J Diabetes; 2015 Oct; 39(5):373-82. PubMed ID: 25862064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.